Aptose Biosciences Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Note 5 - Property and Equipment

Note 5 - Property and Equipment

12 Months Ended

Dec. 31, 2023

Property and equipment:


December 31, 2023	Cost		Accumulated depreciation		Net book value
Laboratory equipment	$	197	$	87	$	110
Computer hardware		29		25		4
Computer software		222		222		0
Office furniture		140		132		8
Leasehold improvements		213		183		30
Total	$	801	$	649	$	152

December 31, 2022	Cost		Accumulated depreciation		Net book value
Laboratory equipment	$	197	$	48	$	149
Computer hardware		198		177		21
Computer software		222		222		—
Office furniture		140		117		23
Leasehold improvements		184		166		18
Total	$	941	$	730	$	211

In the year ended December 31, 2022, the company recorded a loss on disposition of fixed assets of $16 thousand, with these assets having had an original cost of $196 thousand and accumulated depreciation of $180 thousand. There was no loss on disposition of fixed assets in the year ended December 31, 2023. In the years ended December 31, 2023 and December 31, 2022, the Company had additions to fixed assets of $29 thousand and $24 thousand, respectively.